Literature DB >> 34788889

Rolling Up the Sleeve: Equitable, Efficient, and Safe COVID-19 Mass Immunization for Academic Medical Center Employees.

Samuel McDonald1,2, Mujeeb A Basit2,3, Seth Toomay4, Christopher McLarty5, Susan Hernandez5, Chris Rubio5, Bruce J Brown5, Mark Rauschuber5, Ki Lai5, Sameh N Saleh2,6, DuWayne L Willett2,3, Christoph U Lehmann2,7, Richard J Medford2,8.   

Abstract

BACKGROUND: Novel coronavirus disease 2019 (COVID-19) vaccine administration has faced distribution barriers across the United States. We sought to delineate our vaccine delivery experience in the first week of vaccine availability, and our effort to prioritize employees based on risk with a goal of providing an efficient infrastructure to optimize speed and efficiency of vaccine delivery while minimizing risk of infection during the immunization process.
OBJECTIVE: This article aims to evaluate an employee prioritization/invitation/scheduling system, leveraging an integrated electronic health record patient portal framework for employee COVID-19 immunizations at an academic medical center.
METHODS: We conducted an observational cross-sectional study during January 2021 at a single urban academic center. All employees who met COVID-19 allocation vaccine criteria for phase 1a.1 to 1a.4 were included. We implemented a prioritization/invitation/scheduling framework and evaluated time from invitation to scheduling as a proxy for vaccine interest and arrival to vaccine administration to measure operational throughput.
RESULTS: We allotted vaccines for 13,753 employees but only 10,662 employees with an active patient portal account received an invitation. Of those with an active account, 6,483 (61%) scheduled an appointment and 6,251 (59%) were immunized in the first 7 days. About 66% of invited providers were vaccinated in the first 7 days. In contrast, only 41% of invited facility/food service employees received the first dose of the vaccine in the first 7 days (p < 0.001). At the vaccination site, employees waited 5.6 minutes (interquartile range [IQR]: 3.9-8.3) from arrival to vaccination.
CONCLUSION: We developed a system of early COVID-19 vaccine prioritization and administration in our health care system. We saw strong early acceptance in those with proximal exposure to COVID-19 but noticed significant difference in the willingness of different employee groups to receive the vaccine. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34788889      PMCID: PMC8598389          DOI: 10.1055/s-0041-1739517

Source DB:  PubMed          Journal:  Appl Clin Inform        ISSN: 1869-0327            Impact factor:   2.342


  20 in total

1.  What the data say about border closures and COVID spread.

Authors:  Smriti Mallapaty
Journal:  Nature       Date:  2021-01       Impact factor: 49.962

2.  Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investment.

Authors:  Bisola O Ojikutu; Kathyrn E Stephenson; Kenneth H Mayer; Karen M Emmons
Journal:  Am J Public Health       Date:  2020-12-10       Impact factor: 9.308

3.  Planning for a COVID-19 Vaccination Program.

Authors:  Sarah Schaffer DeRoo; Natalie J Pudalov; Linda Y Fu
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

4.  COVID-19 Mass Vaccination Resource Calculator.

Authors:  Grace E Pryor; Kelsea Marble; Ferdinand T Velasco; Christoph U Lehmann; Mujeeb A Basit
Journal:  Appl Clin Inform       Date:  2021-08-18       Impact factor: 2.762

5.  An "Infodemic": Leveraging High-Volume Twitter Data to Understand Early Public Sentiment for the Coronavirus Disease 2019 Outbreak.

Authors:  Richard J Medford; Sameh N Saleh; Andrew Sumarsono; Trish M Perl; Christoph U Lehmann
Journal:  Open Forum Infect Dis       Date:  2020-06-30       Impact factor: 3.835

6.  The Serial Interval of COVID-19 in Korea: 1,567 Pairs of Symptomatic Cases from Contact Tracing.

Authors:  Kwan Hong; Sujin Yum; Jeehyun Kim; Byung Chul Chun
Journal:  J Korean Med Sci       Date:  2020-12-28       Impact factor: 2.153

7.  Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.

Authors:  William Daniel; Marc Nivet; John Warner; Daniel K Podolsky
Journal:  N Engl J Med       Date:  2021-03-23       Impact factor: 91.245

8.  Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous Pandemics.

Authors:  Magali Fassiotto; Hannah Valantine; Tait Shanafelt; Yvonne Maldonado
Journal:  Acad Med       Date:  2021-10-01       Impact factor: 7.840

9.  Understanding public perception of coronavirus disease 2019 (COVID-19) social distancing on Twitter.

Authors:  Sameh N Saleh; Christoph U Lehmann; Samuel A McDonald; Mujeeb A Basit; Richard J Medford
Journal:  Infect Control Hosp Epidemiol       Date:  2020-08-06       Impact factor: 3.254

10.  A global survey of potential acceptance of a COVID-19 vaccine.

Authors:  Jeffrey V Lazarus; Scott C Ratzan; Adam Palayew; Lawrence O Gostin; Heidi J Larson; Kenneth Rabin; Spencer Kimball; Ayman El-Mohandes
Journal:  Nat Med       Date:  2020-10-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.